US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 122.150
  • -4.730-3.73%
Close Jan 8 16:00 ET
  • 122.150
  • 0.0000.00%
Post 20:01 ET
29.28BMarket Cap-61.01P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNTech Q4 2024 Estimates Date

Currency：USDMar 10, 2025

Estimate YoY
Revenue
1.19B
-27.13%
EPS
0.47
-77.40%
Analyst Rating
Strong Buy

Jan 9, 2025

BioNTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 187.267M--
Mar 10, 20252024/Q4-- / 1.143B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 187.267M--
Mar 10, 20252024/Q4-- / 1.143B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--

Unlock Free Earnings Estimates

BioNTech Earnings Reports

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4, 2024 06:59 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4, 2024 06:59 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5, 2024 06:37 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5, 2024 06:37 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 9, 2025

    Strong Buy

    • Buy

      81.25%

    • Hold

      18.75%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday-0.85%